Furthermore, we discover that the sum of the expression values for RNA from the genes, ALDH1A1 and ALDH2, has a stronger association with AML patient risk group classification and survival than either one gene alone does. The gene discussed is ALDH1A1; the disease is acute myeloid leukemia.